Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: Follow-up of the TARGET study cohort (targeted left ventricular lead placement to guide cardiac resynchronization therapy)

JACC: Heart Failure

Volumn 2, Issue 3, 2014, Pages 205-212

  Kydd, Anna C ^a   Khan, Fakhar Z ^a   Watson, William D ^a   Pugh, Peter J ^a   Virdee, Munmohan S ^b   Dutka, David P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Cardiac resynchronization; Long term outcome; Speckle tracking echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PROCEDURE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; LEFT VENTRICULAR LEAD POSITION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ELECTRODE; ENDOSCOPIC ECHOGRAPHY; HEART FAILURE; HEART VENTRICLE; HEART VENTRICLE REMODELING; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PROSTHESIS IMPLANTATION; RANDOMIZED CONTROLLED TRIAL; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; ELECTRODES; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; ULTRASONOGRAPHY, INTERVENTIONAL; VENTRICULAR REMODELING;

EID: 84901682329     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.11.010     Document Type: Article

References (25)

1. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators.
2. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group.
3. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators.
4. Daubert J.C., Saxon L., Adamson P.B., et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012, 14:1236-1286. European Heart Rhythm Association (EHRA); European Society of Cardiology (ESC); Heart Rhythm Society; Heart Failure Society of America (HFSA); American Society of Echocardiography (ASE); American Heart Association (AHA); European Association of Echocardiography (EAE) of ESC; Heart Failure Association of ESC (HFA).
5. Ypenburg C., van Bommel R.J., Delgado V., et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008, 52:1402-1409.
6. Delgado V., van Bommel R.J., Bertini M., et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011, 123:70-78.
7. Singh J.P., Klein H.U., Huang D.T., et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2011, 123:1159-1166.
8. Becker M., Hoffmann R., Kuhl H.P., et al. Analysis of myocardial deformation on the basis of ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J 2006, 27:2560-2566.
9. Geyer H., Caracciolo G., Abe H., et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 2010, 23:351-369. quiz 453-5.
10. Becker M., Zwicker C., Kaminski M., et al. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position. J Am Coll Cardiol Img 2011, 4:366-374.
11. Khan F.Z., Virdee M.S., Palmer C.R., et al. Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012, 59:1509-1518.
12. Saba S., Marek J., Schwartzman D., et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region (STARTER) trial. Circ Heart Fail 2013, 6:427-434.
13. Cleland J.G., Freemantle N., Erdmann E., et al. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 2012, 14:628-634.
14. Gorcsan J., Oyenuga O., Habib P.J., et al. Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy. Circulation 2010, 122:1910-1918.
15. Suffoletto M.S., Dohi K., Cannesson M., Saba S., Gorcsan J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 2006, 113:960-968.
16. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2005, 16:701-707.
17. Khan F.Z., Virdee M.S., Read P.A., et al. Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic study. Europace 2011, 13:845-852.
18. Tanaka H., Nesser H.J., Buck T., et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J 2010, 31:1690-1700.
19. van Bommel R.J., Gorcsan J., Chung E.S., et al. Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT. Heart 2010, 96:1107-1113.
20. Auger D., Bleeker G.B., Bertini M., et al. Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony. Eur Heart J 2012, 33:913-920.
21. Sanderson J.E., Yu C.M. Can cardiac resynchronization therapy cause harm?. Eur Heart J 2012, 33:816-818.
22. Leyva F., Foley P.W., Chalil S., et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011, 13:29.
23. Shetty A.K., Duckett S.G., Ginks M.R., et al. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling. Eur Heart J Cardiovasc Imaging 2013, 14:692-699.
24. Tracy C.M., Epstein A.E., Darbar D., et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012, 60:1297-1313.
25. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.